A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/44 (2006.01) A61K 31/12 (2006.01) A61K 31/15 (2006.01) A61K 31/16 (2006.01) A61K 31/27 (2006.01) A61K 31/325 (2006.01) A61K 31/34 (2006.01)
Patent
CA 2186867
The subject invention involves a method of reducing free radical damage in mammals comprising administering to a mammal a composition comprising a safe and effective amount of a compound selected from 1-phenyl-1,2-propanedione-2-oxime, benzoylacetone, piroctone, 2-furildioxime, 2-furilmonoxime, diethyldithiocarbamic acid, deferoxamine and 1,2-dimethyl-3-hydroxy-pyrid-4-one, or a pharmaceutically acceptable salt thereof, or mixtures of the subject compounds and/or their salts.
La présente invention concerne une méthode pour diminuer les atteintes dues aux radicaux libres chez les mammifères consistant à administrer à un mammifère une quantité suffisante mais sans danger pour la santé d'un composé choisi parmi les composés suivants: 1-phényl-1,2-propanedione-2-oxime, benzoylacétone, piroctone, 2-furyldioxime, 2-furylmonoxime, acide diéthyldithiocarbamique, déféroxamine, 1,2-diméthyl-3-hydroxy-pyrid-4-one, un sel d'un de ceux-ci acceptable sur le plan pharmaceutique, les mélanges de ces composés et/ou leurs sels.
Bissett Donald L.
Shaya Steven Alan
Gowling Lafleur Henderson Llp
The Procter & Gamble Company
LandOfFree
Methods of using iron chelating compounds to reduce free... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of using iron chelating compounds to reduce free..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of using iron chelating compounds to reduce free... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1608904